These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3050402)

  • 1. Comparison of mammary serum antigen assay with mammography in patients with breast cancer.
    Hare WS; Tjandra JJ; Russell IS; Collins JP; McKenzie IF
    Med J Aust; 1988 Oct; 149(8):402-6. PubMed ID: 3050402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of mammography and mammary serum antigen estimation for breast cancer screening.
    Ward BG; Joy GJ; Ramm LE; Baker CA; McGuckin MA
    Med J Aust; 1992 Aug; 157(3):161-4. PubMed ID: 1635488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of mammary serum antigen (MSA) and CA15-3 levels in the serum of patients with breast cancer.
    Sacks NP; Stacker SA; Thompson CH; Collins JP; Russell IS; Sullivan JA; McKenzie IF
    Br J Cancer; 1987 Dec; 56(6):820-4. PubMed ID: 2449238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of mammary serum antigen (MSA) with beta 2-microglobulin (beta 2M) and carcinoembryonic antigen (CEA) assays in patients with breast cancer.
    Tjandra JJ; McLaughlin PJ; Russell IS; Collins JP; McKenzie IF
    Eur J Cancer Clin Oncol; 1988 Oct; 24(10):1633-40. PubMed ID: 3061824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of mammary serum antigen assay in the management of breast cancer: a preliminary report.
    Tjandra JJ; Russell IS; Collins JP; Stacker SA; McKenzie IF
    Br J Surg; 1988 Aug; 75(8):811-7. PubMed ID: 3048535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of breast cancer imaging with radiolabeled antibodies to carcinoembryonic antigen. Immunomedics Breast Cancer Study Group.
    Goldenberg DM; Wegener W
    Acta Med Austriaca; 1997; 24(2):55-9. PubMed ID: 9227788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts: interval breast cancers at 1 year follow-up.
    Corsetti V; Houssami N; Ghirardi M; Ferrari A; Speziani M; Bellarosa S; Remida G; Gasparotti C; Galligioni E; Ciatto S
    Eur J Cancer; 2011 May; 47(7):1021-6. PubMed ID: 21211962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved detection rate of early breast cancer in mass screening combined with mammography.
    Ohuchi N; Yoshida K; Kimura M; Ouchi A; Kamioki S; Shiiba K; Matoba N; Kojima S; Takahashi K; Matsuno S
    Jpn J Cancer Res; 1993 Jul; 84(7):807-12. PubMed ID: 8396569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The squamous cell carcinoma tumor marker in mammary carcinoma: comparison of polyclonal versus monoclonal antibody-based assays.
    Wobbes T; Thomas CM; Segers MF
    Oncology; 1990; 47(1):14-8. PubMed ID: 2300380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of an immunoradiometric assay for CA15-3 antigen associated with human mammary carcinomas: comparison with carcinoembryonic antigen.
    Fujino N; Haga Y; Sakamoto K; Egami H; Kimura M; Nishimura R; Akagi M
    Jpn J Clin Oncol; 1986 Dec; 16(4):335-46. PubMed ID: 3467106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The correlation between the immunohistochemical expression of DF3 antigen and serum CA15-3 in breast cancer patients.
    Ohuchi N; Sato S; Akimoto M; Taira Y; Matoba N; Takahashi K; Mori S
    Jpn J Surg; 1991 Mar; 21(2):129-37. PubMed ID: 1646903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of mammary serum antigen (MSA) with the histopathological findings in localised breast cancer.
    Tjandra JJ; Busmanis I; Russell IS; Collins JP; Reed RG; McKenzie IF
    Br J Cancer; 1988 Dec; 58(6):815-7. PubMed ID: 2852030
    [No Abstract]   [Full Text] [Related]  

  • 13. Pretreatment concentrations of breast carcinoma antigen (CA 15.3) and mucin-like carcinoma-associated antigen in patients with carcinoma of the breast.
    Góźdź SS; Kowalska MM; Słuszniak JT; Słuszniak A; Korejba W; Bukowski J; Banasińska E; al-Jazzaf H; Szymendera JJ
    Tumour Biol; 1989; 10(2):103-8. PubMed ID: 2734547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer: new technologies for risk assessment and diagnosis.
    Wright T; McGechan A
    Mol Diagn; 2003; 7(1):49-55. PubMed ID: 14529321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
    May DS; Lee NC; Nadel MR; Henson RM; Miller DS
    AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nipple fluid carcinoembryonic antigen and prostate-specific antigen in cancer-bearing and tumor-free breasts.
    Zhao Y; Verselis SJ; Klar N; Sadowsky NL; Kaelin CM; Smith B; Foretova L; Li FP
    J Clin Oncol; 2001 Mar; 19(5):1462-7. PubMed ID: 11230492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of mammary serum antigen in sera from breast cancer patients using monoclonal antibody 3E1.2.
    Stacker SA; Thompson CH; Sacks NP; Tjandra J; Lowe MG; Bishop J; McKenzie IF
    Cancer Res; 1988 Dec; 48(24 Pt 1):7060-6. PubMed ID: 3191482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer screening by mammography in women aged under 50 years in Japan.
    Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
    Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk.
    Lee JM; Arao RF; Sprague BL; Kerlikowske K; Lehman CD; Smith RA; Henderson LM; Rauscher GH; Miglioretti DL
    JAMA Intern Med; 2019 May; 179(5):658-667. PubMed ID: 30882843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of MSA as a serum marker in breast cancer: a comparison with CEA.
    Stacker SA; Sacks NP; Golder J; Tjandra JJ; Thompson CH; Smithyman A; McKenzie IF
    Br J Cancer; 1988 Mar; 57(3):298-303. PubMed ID: 3355770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.